<DOC>
	<DOCNO>NCT00890175</DOCNO>
	<brief_summary>The purpose study assess safety 2 inhaled dos Staccato Loxapine within day patient asthma .</brief_summary>
	<brief_title>Staccato Loxapine Pulmonary Safety Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Loxapine</mesh_term>
	<criteria>History mild moderate persistent asthma least 6 month prebronchodilator FEV1 â‰¥60 % predict value . History COPD , acute chronic pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Asthma , Staccato loxapine</keyword>
</DOC>